- Beurer GmbH
- GF Health Products Inc.
- PARI GmbH
- Allied Healthcare Products Inc.
- Aerogen Ltd.
- Briggs Healthcare
- OMRON Corporation
- Rossmax Swiss GmbH
- Vectura Group plc.
- Becton, Dickinson and Company
- General Electric Company
- Agilent Technologies Inc.
- Medline Industries Inc.
- Koninklijke Philips N.V.
(Note: The list of the major players will be updated with the latest market scenario and trends)
Recent developments by key players in Nebulizer Market:
In July 2022, Ziccum inked a contract with TEKCELEO, a creative mechatronic company with extensive nebulizer experience, to develop its latest nebulizer.
In recent years, the nebulizer market has grown significantly, propelled by a number of crucial factors. One of the primary drivers is the rising prevalence of respiratory illnesses such as cystic fibrosis, COPD, and asthma. According to the World Health Organization, asthma affects around 339 million people globally, while COPD affects around 251 million people. These figures are expected to rise in the coming years, driving demand for nebulizers. Another factor driving growth in the nebulizer market is the increasing adoption of home healthcare services. With the rise of chronic diseases, patients are increasingly opting for home-based treatment options, including the use of nebulizers. Home healthcare services are particularly popular among the elderly and patients with mobility issues, who may find it challenging to visit hospitals or clinics for treatment. Moreover, technological advancements in nebulizers have also contributed to the growth of the market. The development of portable nebulizers has made it easier for patients to receive treatment anytime and anywhere without requiring a power supply or compressor. In addition, the development of vibrating mesh nebulizers, which use a vibrating mesh to generate a fine mist of medication, has also increased the efficiency and effectiveness of nebulizers.
Despite the growth prospects, there are also several challenges faced by the nebulizer market. One of the significant challenges is the high cost of nebulizers, which can be a barrier to access for some patients.